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Abstract
A causal role of fructose intake in the aetiology of the global obesity epidemic has been proposed in recent years. This proposition, how-
ever, rests on controversial interpretations of two distinct lines of research. On one hand, in mechanistic intervention studies, detrimental
metabolic effects have been observed after excessive isolated fructose intakes in animals and human subjects. On the other hand, food
disappearance data indicate that fructose consumption from added sugars has increased over the past decades and paralleled the increase
in obesity. Both lines of research are presently insufficient to demonstrate a causal role of fructose in metabolic diseases, however. Most
mechanistic intervention studies were performed on subjects fed large amounts of pure fructose, while fructose is ordinarily ingested
together with glucose. The use of food disappearance data does not accurately reflect food consumption, and hence cannot be used as
evidence of a causal link between fructose intake and obesity. Based on a thorough review of the literature, we demonstrate that fructose,
as commonly consumed in mixed carbohydrate sources, does not exert specific metabolic effects that can account for an increase in body
weight. Consequently, public health recommendations and policies aiming at reducing fructose consumption only, without additional
diet and lifestyle targets, would be disputable and impractical. Although the available evidence indicates that the consumption of
sugar-sweetened beverages is associated with body-weight gain, and it may be that fructose is among the main constituents of these
beverages, energy overconsumption is much more important to consider in terms of the obesity epidemic.
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Introduction
Several studies and reports(1–8) have indicated an
increased consumption of sugar-sweetened beverages
(SSB) over the period 1970–2005 in the USA and Europe.
The SSB category includes sodas (soft drinks), fruit
drinks, sports drinks, ready-to-drink sweetened tea and
coffee, rice drinks, bean beverages, sugared milk drinks,
sugar cane beverages and non-alcoholic wines or malt
beverages. The increased intake was related to a high
availability of such products in the market, amplified
marketing efforts, and larger portion sizes, which increased
three- to five-fold over time(9). As such, SSB consumption
was suggested to be a considerable amount of total daily
energy intake(10).
Interestingly, over the last 5 years, the global annual con-
sumption of carbonated soft drinks has remained constant
or even has declined(11), while bottled water has increased
to more than 1 litre per individual per year in recent
years(12). Obesity rates, however, seem to have increased
independently of these shifts in beverage intake(13). An
overview of the average Western European consumption
of the five most common drink categories, including
SSB, per capita per year are given in Table 1(14). Data
from the USA are given in Table 2(15). Note that in the
USA, carbonated water is replaced by sports drinks in the
five most consumed categories.
Although data from Table 1 and Table 2 were obtained
through trade sources and national statistics (by Euromoni-
tor International(14,15)), which did not account for wastage
and were not corrected for export to other countries, it can
be concluded that, even if intake patterns are shifting,
consumers in different parts of the world still purchase
a relatively high amount of SSB.
In this light, the systematic reviews by Malik et al.(16) in
2006 and Hu & Malik(17) in 2010 concluded that such
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quantities of SSB consumption were associated with both
weight gain and type 2 diabetes prevalence. Moreover,
results from a survey in Australia indicated that high SSB
intake may be an important predictor of cardiometabolic
risk(18). A scientific opinion by the European Food Safety
Authority (EFSA)(19), however, concluded that additional
justification for the correlation between SSB consumption
and such adverse health effects was required.
In this respect, one may question what in SSB could be
responsible for these adverse effects on health(20). More
specifically, first, is there evidence that specific sugars,
such as fructose and glucose, as present in sucrose and
high-fructose corn syrup (HFCS), promote excess energy
intake? Second, is there evidence that excess energy
intake as sugars is more detrimental to health than excess
energy as fat, or as complex carbohydrate present in
potatoes, rice, refined cereals, and so forth?(21).
Since the recent publications of Lustig and co-
workers(22,23), in which it was suggested that fructose is
toxic and should be ‘treated as alcohol’, the daily news
all over the world highlighted fructose in SSB as a potential
poison. It was proposed that fructose is a causal factor in
obesity aetiology, based on the scientific evidence that
substantiated that fructose, when consumed in excessive
amounts, led to detrimental effects on body-weight regu-
lation, lipid metabolism and glucose homeostasis in
animals and in human subjects(24–27). As a result, an overall
reduction in the global consumption of fructose-containing
sugars was recommended in recent literature(1,4,16,28–36).
To achieve this reduction, various measures have been
proposed(37), most of which related to extra taxes on
foods, such as SSB, that are considered unhealthy because
of their high fructose content(38–43). However, raising tax
levels, and consequently purchase prices, has generally
failed to change consumption behaviours(44). In line with
this, also the removal of products from the site of avail-
ability has been discussed as possibly inappropriate in
changing purchase behaviour, since it may result in
exchanging the purchase with similar products(45). In the
field studies of Wansink et al.(45), it was evidenced that
taxing soft drinks in Utica (New York State) led beer-
buying households to increase their purchases of beer.
Similarly, taking out snacks and soft drinks from vending
machines did not withhold children from buying such
products at other locations or finding other alternatives
that are also high in sugars, fat, and energy-dense.
Moreover, as the human body does not differentiate fruc-
tose absorption, whether it comes from HFCS, cane or beet
sugar, or from an intrinsic source such as that present in
fruits or fruit juices(19,46,47), would this reduction also be
necessary for fruits that contain relatively large amounts
of fructose such as apples, apricots and ripe bananas?
Should honey also be removed from our diet(48)? These
questions have confused the typical consumer of sweet
(and sweetened) food products(49). This confusion may
have been intensified by the issuing of a scientific opinion
on fructose by EFSA in 2011. With this, European food
manufacturers can claim that ‘consumption of fructose
leads to a lower blood glucose rise than consumption
of sucrose or glucose’(50). Having evaluated the scientific
literature at their disposal(47,51–57), the EFSA panel assumed
that, when fructose replaces sucrose or glucose in foods or
beverages, the claimed effect will be obtained. The panel
took into account two human intervention studies(51,52)
that showed a consistent significant reduction in post-
prandial glycaemic responses. This occurred without
disproportionally increasing postprandial insulinaemic res-
ponses. Further, the panel noted that the mechanism by
which fructose (when replacing sucrose or glucose) in
food or beverages could exert the claimed effect was
well established.
The panel did note that high intakes of fructose (set at
$25 % of total energy) was shown to lead to metabolic
complications such as dyslipidaemia, insulin resistance
and increased visceral adiposity, based on several review
articles(47,53–56). With this scientific opinion, and related
health claim, the panel clearly took a different position
from the opinion that fructose is toxic and should be
treated as alcohol.
So, what is the current status concerning the role of
fructose-containing SSB that supply glucose along with
fructose? Identifying added fructose as a prime cause of
obesity can be misleading to the public, as well as policy
makers, about the ‘truth of obesity’ in the case that
causality remains unproven. Obesity is recognised to be a
multiple-factor-related health problem(58), in which life-
style factors(59), eating behaviour(60) and socio-economic
aspects(61) all play a key role, and fructose intake may be
Table 1. Average Western European consumption of the five most
common drink categories, including sugar-sweetened beverages(14)
European average yearly
consumption (litres per person)
Drink category 2007 2008 2009 2010 2011 2012
Still bottled water 54·0 55·2 55·6 56·3 57·5 58·5
Cola carbonates 28·4 28·7 29·4 30·1 30·7 31·0
Carbonated bottled water 28·2 27·4 27·2 27·1 27·4 27·7
Non-cola carbonates 20·7 20·6 20·8 20·9 20·9 20·9
100 % Juice 12·9 12·5 12·1 11·9 11·5 11·2
Table 2. Average US consumption of the five most common drink
categories, including sugar-sweetened beverages(15)
US yearly average consumption
(litres per person)
Drink category 2007 2008 2009 2010 2011 2012
Still bottled water 70·3 68·0 66·5 66·2 68·2 70·9
Cola carbonates 71·5 67·9 65·0 62·8 59·5 56·5
Non-cola carbonates 56·1 54·9 54·0 54·9 55·7 55·9
Sports drinks 16·3 15·4 13·9 14·8 17·0 17·3
100 % Juice 16·5 16·4 16·4 15·6 14·8 14·3
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just one among several factors involved in its prevalence.
At present, there are reasons to believe that isolated
reductions in added fructose-containing sugar intake, as
recently investigated(62,63), will not lead to a decrease
in obesity prevalence. When similar isolated reductions
were undertaken concerning added fats(64), the desired
overall reduction in fat intake and development of
low-fat/light products were not observed(65).
Fructose is considered by some authors to be a signi-
ficant culprit for obesity and related disorders based on
three categories of arguments:
(1) Arguments that generalise data derived from animal
models of obesity (in which sugar overfeeding was used
as an experimental tool to increase body weight) as well
as human studies in which excessive fructose intakes
were used to study the mechanisms of metabolic
dysregulation.
(2) Arguments that confuse the relative contents of
glucose and fructose in industrially produced food and
beverages.
(3) Arguments that underestimate our personal
responsibility to remain physically active and to consume
a healthy diet.
A plethora of unbalanced reviews on the topic have
recently been published(23,66,67), including citations to
other reviews instead of addressing the authentic data.
In the present review, we therefore look at evidence
regarding both positive and negative effects of fructose
and fructose-containing sugar sources on obesity, as
described in recent peer-reviewed research papers.
Metabolic effects of fructose
In order to study the effects of fructose on metabolism,
scientists have generally used dosages high enough to
observe some significant effects, mostly in animal studies
and sometimes in human intervention research. Based on
recent publications(27,56,68,69), we summarise a number of
key findings from studies with high to excessive fructose
intakes. It is important to note that fructose intake varies
between individuals, based on their daily consumption
patterns(70). Through a 2008 US survey in 21 483 children
and adults, it was found that the mean intake of fructose
was 9·7 (standard error of difference 0·1) % of total
energy intake, and that 95 % of these sampled individuals
consumed less than 19·5 (standard error of difference
0·7) % of fructose as part of their total energy intake(70).
Therefore, in the discussion below, we assume fructose
intake to be excessive if its pure intake amount is larger
than 20 % of daily energy.
Effects of excessive doses of fructose
Already in 1993, researchers(71) agreed that excessive fruc-
tose consumption (then defined as 7·5 % to 70 % of total
energy intake) induces immediate de novo lipogenesis in
both animals and humans, because, in different exper-
imental settings, it circumvented substrate inhibition feed-
back mechanisms that are present for glucose when it
enters glycolysis. It was shown that the dietary fructose
fraction not converted to lactate in the intestinal epithelium
was rapidly taken up by the liver, where it was sub-
sequently converted first into fructose-1-phosphate, and
then to triose-phosphate and pyruvate/lactate. These are
both potential substrates for liver glycogen synthesis and
for fatty acid production, leading to an increased TAG
release from the liver into blood. Also, it was found that
fructose stimulated key lipogenic enzymes by activating
sterol regulatory element-binding protein-1c (SREBP-1c)
in the livers of mice(72).
In addition, it was found that high fructose loads (50 % of
total diet) led to an increase in PPARg co-activator 1a and
1b (PGC-1a and PGC-1b) which promoted insulin resist-
ance and lipogenesis(73,74), as well as decreased insulin
receptor activation and insulin receptor substrate phos-
phorylation(75). Subsequently, lipogenesis induced by this
high fructose load was associated with the formation of
larger fat deposits in adipose tissue and muscle, in
animal models(73,74). However, to the best of our knowl-
edge, there are no results of long-term human intervention
studies available in which comparable quantities of fruc-
tose were investigated. One short-term intervention study
(96 h) examined the effects of 50 % excess energy as fruc-
tose, sucrose or glucose, and indicated that, even under
these drastic conditions, de novo lipogenesis remained a
minor pathway for fructose disposal in both lean and
obese women(76).
Hyperuricaemia may occur as a consequence of rapid
fructose entry from portal blood into the liver, where fruc-
tose will reduce the total adenosine nucleotide (TAN) pool
in liver cells. A degradation of hepatic TAN will result in the
production of uric acid. In a within-subjects intervention,
this was measured in obese men and women where pure
fructose intake provided 30 % of total energy intake(77).
Chronic hyperuricaemia was also proposed to act as a
promoter of insulin resistance and type 2 diabetes deve-
lopment(78). Based on recent findings from in vivo research
in fructose-fed rats, it was suggested that uric acid may
impair the action of insulin by decreasing insulin-mediated
muscle vasodilatation(79). In addition, it may possibly act
as an intracellular mediator to enhance hepatic de novo
lipogenesis(80). It remains unclear if these metabolic con-
sequences can occur in humans considering moderate
fructose intake level and complex dietary composition.
We will discuss this in detail below.
In older adults consuming fructose daily through SSB,
fructose led to stressful conditions in hepatocytes(81) result-
ing in the release of TNF-a, a strong pro-inflammatory
messenger involved in insulin resistance development(82).
Also in rats, excessive fructose intake (.62 % of total energy)
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induced oxidative stress, mitochondrial and endothelial
dysfunction, resulting in hypertension(83).
In summary, it appears that excessive fructose intake
can have deleterious metabolic effects in both animals
and humans.
Disputable interpretations
In contrast to these deleterious effects observed in animal
models and in human trials with excessive intakes, the
metabolic effects of fructose presented in ordinary
human diets remain poorly investigated and highly contro-
versial. The assumption that fructose was directly involved
in the occurrence of obesity relied on correlation data
between the increase in HFCS consumption and obesity
prevalence in the USA. This assumption has been
considered as misleading for several reasons.
First, the correlation of HFCS and obesity data only
happened in North America. In Europe, there was also
an increase in obesity prevalence during the same
period, but HFCS was not consumed to any significant
amount. Moreover, the term HFCS often led individuals
to believe that it had a very high fructose content. In
fact, the relative proportion of fructose to glucose in
HFCS 55 (55 % fructose; used in most soft drinks) and
HFCS 42 (42 % fructose; mostly used in non-beverage appli-
cations) is not that different from sucrose (50:50 %)(46),
although absolute levels as analysed in drinks may vary.
In this respect, free fructose content in sucrose-sweetened
acid-containing beverages, such as colas, was found to
be increased during storage due to acid-induced sucrose
hydrolysis(84,85).
A prospective cohort study(86) indicated that higher
consumption of SSB was associated with a higher risk of
CHD. Additionally, a cross-sectional study(34) and two
other cohort studies(87,88) positively associated a reduction
in SSB consumption with a reduction of disease risk factors
such as elevated blood pressure or weight gain. It should
be mentioned, however, that relevant intervention studies
with such risk factors as end-point are lacking. Interest-
ingly, four large cohort studies showed no relationship
between moderate sugar intake and type 2 diabetes(89–92).
The question of whether the aforementioned effects are
really caused by fructose can therefore not be answered
by the observational data since these show associations,
not causality.
In this respect, it is important to note that through
analysis of the same set of data, a positive association
between obesity risk and SSB intakes was found without
adjustment for total energy intake(93). These outcomes
from the modelling analyses may indicate that SSB
consumption was not associated with obesity risk if poten-
tial impact of total energy intake was accounted for. In this
light, a meta-analysis(93), a descriptive time-series study(94)
and a cohort study(95) did report a relationship between
sugar intake or SSB intake and diabetes, dyslipidaemia
and cardiometabolic risk factors. In all these studies, how-
ever, the relationship disappeared when the analysis was
adjusted for body weight, strongly suggesting that obesity
rather than sugar intake may be the factor associated
with the disease status or biomarkers mentioned.
Goran et al.(96) did find that diabetes prevalence was
20 % higher in European Union (EU) countries with a
higher availability of HFCS, as compared with countries
with low availability. The authors stated that these differ-
ences were retained after adjusting for country-level
estimates of BMI, population and gross domestic product.
An analysis of the study, however, shed an interesting
light on the reliability of these findings. The cited HFCS
consumption data for the EU countries were, in fact, not
consumption data at all but rather production data. In
the EU, HFCS travels freely across EU borders and can
thus be consumed anywhere. For instance, the article
stressed that Hungary consumed significant amounts of
HFCS and also showed a higher prevalence of diabetes(97).
In reality, most HFCS from Hungary, which was one
of Europe’s leading producers of this ingredient, was
exported(98). Consumption and production figures are, as
such, two entirely different things. Even if export and
import figures were accounted for, food spoilage (which
can be up to 30 %(99)) makes a serious impact on the
above findings. This is also the case in many other
epidemiological research papers that have used sugar pro-
duction or disappearance data as the bases for correlations
with obesity, as well as papers that cite such data for build-
ing their arguments. More recently, Basu et al.(100) used
food supply data from the UN FAO to capture the market
availability of different food items worldwide. From this,
the authors concluded that an increase in sugar availability
was associated with higher diabetes prevalence after test-
ing for potential selection biases and controlling for other
food types, total energy intake, overweight and obesity,
period effects, and several socio-economic variables such
as ageing, urbanisation and income. As discussed, the
market availability of food is a debatable indicator for
sugar consumption.
In this respect, a recent New York Times article by
Strom(101) pointed out that, due to incorrect methodology,
as discussed by Muth(102), US sugar consumption in recent
years has been overestimated by .20 %. Interestingly, the
author implied that sugar consumption has not risen sub-
stantially since the 1980 s. This makes many assumptions
based on higher production or per capita consumption
data unsubstantiated. In addition, data obtained from the
US National Health and Nutrition Examination Surveys, in
2005–2010(21), concluded that total energy from added
sugars remained rather constant, or even declined in
some segments of the population, in recent years. More-
over, the consumption of added sugar through beverages
contributed to only one-third of total added sugar intake,
indicating that the energy from added sugars mostly
came from foods rather than beverages.
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Alternative and balancing views
In animal models, excessive-fructose diets lead to
hyperphagia, obesity and the development of a metabolic
syndrome(27). In human subjects, however, evidence is
scarce. Short-term studies that used large amounts of
fructose have led to relatively modest changes in meta-
bolic profile (including hypertriacylglycerolaemia) and a
moderate decrease in hepatic insulin sensitivity and no
change in whole-body/muscle insulin resistance(47,103,104).
This may suggest that there is a large metabolic plasticity
in response to dietary changes and what we observe are
minor adjustments of metabolic pathways rather than
pathogenic events.
There has been no evidence that relatively high levels
of SSB consumption could be associated with obesity,
diabetes or cardiometabolic risk in professional athletes
who usually consume SSB as energy and dehydration
drinks. On the other hand, there is evidence that physical
inactivity, even within a few days, causes insulin resistance
and dyslipidaemia in normal healthy individuals(105). In
this regard, two randomised within-subjects studies in
healthy males and females showed that higher plasma
TAG concentrations, induced by a high-carbohydrate diet,
were completely prevented by physical activity(106,107).
Thus, the metabolic consequences of a high mixed
glucose–fructose intake can be significantly modulated
by exercise. In a narrative review(108), it was reported
that high fructose consumption induces insulin resistance,
impaired glucose tolerance, hyperinsulinaemia, hypertria-
cylglycerolaemia and hypertension in animal models. The
data in human subjects, however, were considered less
clear. In this respect, fructose consumption, even in large
amounts (17 % of total energy), did not result in significant
effects in healthy males but did cause these effects in
healthy women(109). Moreover, such fructose consumption
did not stimulate de novo lipogenesis in premenopausal
women(110,111). In a review addressing sugars, insulin sen-
sitivity and the postprandial state(112), it was concluded that
research on animals, particularly rodents, has shown a
clear and consistent effect of high-sucrose and high-
fructose diets in decreasing insulin sensitivity. Again, it
was underlined that experiments in human subjects have
produced very conflicting results, as there is only limited
evidence from human consumption data, using fructose
levels of higher than 15 % of daily energy intake, for such
an effect on insulin sensitivity.
If it is not fructose, is it just added sugars in a solution?
The suggestion that HFCS is causal to obesity(32,113) cannot
explain why overweight and diabetes have also increased
over the past decades in regions where HFCS is not
(or is hardly being) used in soft drinks (for example,
Europe and India), or where SSB consumption is limited
(Asia and Africa)(114).
Several reviews and position papers have proposed
that SSB are causally related to obesity because energy-
containing liquids do not elicit the same satiety signals as
energy-containing solid foods(17,115–118). This hypothesis
was partially supported by studies that showed that sup-
plementation with SSB increased body weight, and thus
that the intake of energy from other sources was not ade-
quately suppressed(62,63). In such studies, however, the
cumulated weight gain observed was substantially lower
than expected from added SSB energy, indicating that
there was at least partial compensation(117,119). This com-
pensatory effect and other problems in this research area
were highlighted recently by Allison(120) and quantified
by Kaiser et al.(20). In their meta-analysis(20), the observed
weight gain from six randomised controlled trials in
which the effect of SSB on weight gain was tested was
compared with the theoretical weight gain in these studies.
It was found that the observed data were, on average, 85 %
lower than the theoretical weight gain, indicating a high
compensation effect. In other words, the effect of added
sugars on weight gain was much smaller than the theoreti-
cally assumed result. This does not mean that a frequent
consumption of SSB does not make an impact on weight
gain. It does show, however, that other factors do contri-
bute significantly as well.
In a recent cross-sectional study, it was reported that US
adolescents, who consumed high amounts of added sugars
(20–30 % of total energy), had higher blood cholesterol
and TAG compared with low sugar consumers (10–20 %
of total energy)(121). High sugar consumers had similar
body weight and total energy intake compared with low
sugar consumers, but a lower intake of energy from fat
and protein, indicating that sugar intake was at least
partially compensated(121). Several smaller studies(122,123)
documented that liquid sugar preloads significantly reduce
spontaneous food intake at subsequent buffet meals and
that fructose was as efficient as glucose – in some instances
even more efficient – in this regard.
Thus, these data provide a basis for arguments against
the hypothesis that fructose-containing liquids have a
different effect on satiety, since all energy-containing
beverages seem to have similar effects(124). This has led
Moran(125) to conclude that results have been inconsistent
and that particular findings concerning the effects of
fructose on satiety appear to depend on the timing,
eating context and volume of preload relative to the test
meal. Another study(126) listed the effect of fructose on
body weight in controlled feeding trials. Herein, the
authors concluded that fructose does not seem to cause
weight gain when it is substituted for other carbohydrates
in diets providing similar energy content. In this respect,
the question arises whether consuming energy through
beverages results in fewer satiety signals compared with
energy from solid foods. To answer this, the US 2010
Dietary Guidelines Advisory Committee(127) reviewed the
literature and concluded: ‘A limited body of evidence
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shows conflicting results about whether liquid and solid
foods differ in their effects on energy intake and body
weight, except that liquids in the form of soup may lead
to decreased energy intake and body weight.’
Most recently, Page et al.(128) performed a study on
neurophysiological factors that might underlie associations
between fructose consumption and weight gain. For this
purpose, twenty healthy adult volunteers underwent two
MRI sessions at Yale University in conjunction with fructose
or glucose drink ingestion in a blinded, random-order, cross-
over design. The authors concluded that glucose but not
fructose ingestion reduced the activation of the hypothala-
mus, insula and striatum – brain regions that regulate appe-
tite, motivation and reward processing. Glucose ingestion
also increased functional connections between the hypo-
thalamic–striatal network and increased satiety. The dispa-
rate responses to fructose were associated with lower
systemic levels of the satiety-signalling hormone insulin
and were not probably attributable to an inability of fructose
to cross the blood–brain barrier into the hypothalamus, or to
a lack of hypothalamic expression of genes necessary for
fructose metabolism. The authors discussed a number of
limitations of this well-designed study, but did not consider
the possibility that the observed effects were merely
mediated by hyperinsulinaemia present after glucose, but
not after fructose, ingestion. They also did not discuss that,
in real life, fructose is never consumed as a single carbo-
hydrate source but always together with glucose. Thus, diet-
ary intakes of sucrose and HFCS all raise insulin levels
significantly, and should not induce the observed brain
responses to feeding fructose alone.
Fructose and obesity
As discussed, it is generally believed that the consumption
of fructose leads to an immediate increase in lipid synthesis
in the liver and a subsequent increase in circulating TAG.
This assumed relationship between fructose, lipid synthesis
and hypertriacylglycerolaemia has been extrapolated to
obesity(28,32). However, careful studies in human subjects,
using stable isotopes, do not confirm this relationship.
Chong(129) observed that, after a load of 0·75 g fructose
per kg body weight, the enhanced postprandial elevation
of plasma TAG is mainly explained by a small impact of
fructose on insulin compared with glucose, reducing TAG
clearance, rather than as a result of new synthesised lipids
which appeared to be small. Given the fact that about
50 % of a fructose load is converted into glucose, 25 % into
lactate, and approximately 15 % into glycogen, de novo
lipogenesis is a minor pathway for fructose disposal(56).
This is in line with the substantial evidence reviewed
by Hellerstein et al.(130), who summarised the evidence as
follows:
(1) After consumption of a normal diet, ,3 % of post-
absorptive VLDL was estimated to come from sugar;
(2) In the fed state, ,5–7 % of VLDL post-absorptive
comes from sugar;
(3) When given 250 g fructose within 6 h, ,10 % of the
fructose load was converted to lipids, equivalent to ,1g/h
in absolute amounts;
(4) Daily overfeeding with 150–200 g fat and 750–1000 g
carbohydrates led to a de novo synthesis of 5 g fat per d,
equivalent to ,3 % of the total fat consumed.
Accordingly, Hellerstein et al.(130) concluded that de novo
net lipogenesis, after fructose or sugar consumption, is in
fact very small. The explanation for these observations is
that the consumed carbohydrates are primarily cleared
from the blood, to be oxidised in energy metabolism
and/or stored as glycogen, at the expense of fat oxidation
which drops due to lipolysis inhibition by insulin and
reduced NEFA availability. Thus, only very small amounts
of lipids are synthesised after large fructose, sugar or
carbohydrate loads, unless extreme carbohydrate over-
loading is sustained for several days(131).
Very recently, Sun & Empie(132) reviewed isotopic tracer
studies in human subjects. The authors summarised their
findings as follows: ‘Fructose is readily absorbed and its
absorption is facilitated by the presence of co-ingested glu-
cose. Sucrose, honey, 50:50 glucose-fructose mixtures and
HFCS all appear to be similarly absorbed. Fructose itself is
retained by the liver, while glucose is mainly released into
the circulation and utilized peripherally. Plasma levels of
fructose are an order of magnitude (10–50 folds) lower
than circulating glucose, and fructose elicits only a
modest insulin response.’ Further, the authors stated that
the average oxidation rate of fructose was similar in non-
exercising and exercising conditions (45·0 and 48·8 %,
respectively). Moreover, they underscored that when fruc-
tose is ingested together with glucose, the mean oxidation
rate of the mixed sugars increased significantly.
In their review, Sun & Empie(132) described the meta-
bolic fate of pure fructose based on several studies. Follow-
ing 3–6 h after ingestion, on average 41 (SD 10·5) %
fructose was converted to glucose. Only a small percentage
of ingested fructose (,1 %) was directly converted to
plasma TAG. Approximately one-quarter of ingested fruc-
tose was converted into lactate within a few hours. They
discussed further that the observed increases in plasma
TAG and de novo lipogenesis, as observed in various
studies, can arise from both increased lipid synthesis and
decreased lipid clearance, and that the relative contri-
butions were not addressed in any detail in the available
studies. Furthermore, the fate of fructose ingested together
with glucose had received little attention so far. In addition,
habitual fructose intake, health status (and more specifi-
cally insulin resistance), sex, or ethnic/genetic background
were all-important factors that may modulate sugar–lipid
relationships but had not yet been adequately investigated.
Accordingly, the influence of fructose consumption on
plasma lipids and de novo lipogenesis remains controver-
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sial and understudied and conclusions that fructose is a
liver toxin similar to alcohol are certainly premature.
Fructose, uric acid and insulin resistance
In 2009, Johnson et al.(133) hypothesised that excessive
fructose intake (.50 g/d) may be one of the underlying
factors in the aetiologies of the metabolic syndrome and
type 2 diabetes. The authors suggest that this occurs
through mechanisms by which rapidly increased fructose
phosphorylation in liver cells results in total adenine
nucleotide degradation leading to the liberation of elevated
uric acid, leading to higher cardiovascular risk(134). In a
study of Sa´nchez-Lozada et al.(135), rats were fed either a
combination of 30 % fructose and 30 % glucose or 60 %
sucrose, while control rats were fed normal rat chow con-
taining 60 % maize starch. Diets containing 30 % of either
both free fructose and free glucose, or as the disaccharide
sucrose, induced the metabolic syndrome, intra-hepatic
accumulation of uric acid and TAG, leading to fatty liver.
Relevant for the interpretation of this study is that the
level of fructose consumed by the rats was excessive and
does not reflect levels consumed by humans.
Another study, by Abdelmalek et al.(91), investigated
twenty-five diabetic adults receiving an intravenous fruc-
tose challenge. Based on their data, the authors concluded
that high fructose consumption depletes hepatic ATP and
impairs recovery from ATP depletion after an intravenous
fructose challenge. This approach, however, relied on the
intravenous administration of .25 g of pure fructose
(250 mg/kg body weight) within 1 min, resulting in a
massive hepatic disposal. Similar ATP depletion has also
been observed with large oral fructose load, but led to
only small increases in uric acid concentrations in healthy
subjects(136). However, it has been recently reported that
ingestion of even larger amounts of fructose failed to
acutely increase uric acid concentration when ingested in
split doses throughout several days, suggesting that liver
ATP depletion is unlikely to occur with usual patterns of
sugar consumption(137).
Lin et al.(138) also observed that fructose consumption
resulted in higher serum uric acid levels in individuals
with a BMI of .30 kg/m2. Interestingly, their study
showed that there was no effect of fructose intake in the
subjects with a BMI between 25 and 29 kg/m2, although
serum uric acid showed a trend to be elevated depending
on body-weight status. Moreover, the blood samples were
drawn after an overnight fast in the morning, ruling out any
postprandial effect of fructose ingestion. Accordingly, the
effect on serum uric acid was more likely to be secondary
to obesity or the metabolic syndrome than to fructose con-
sumption per se. In this study, intake was calculated from
food frequency recall, which is known to have a low
level of accuracy(139). Moreover, food frequency intake
data are based on food composition tables that are not
controlled for recipe-related changes in food and beverage
products on the market. This double chance of error
should not be neglected.
Limited data are available on serum uric acid
changes after realistic dietary loads of fructose-containing
sugars(140). For example, Akhavan & Anderson(141) tested
solutions containing different ratios of glucose and fruc-
tose. In their study, overnight-fasted men received a stan-
dardised breakfast in the morning. At 4 h later, a 300 kcal
(1255 kJ) drink was ingested within 3 min. The solutions
were sweetened with either HFCS containing 55 % of
fructose, sucrose or the monosaccharide forms of glucose
and fructose in specific ratios as follows: 80 % glucose:
20 % fructose (G80:F20), sucrose, G50:F50, G35:F65 and
G20:F80. At 75 min, uric acid concentrations were highest
after G20:F80. The sucrose and F50:G50 solutions each
resulted in significantly lower uric acid concentrations
than did the G20:F80 solution, but they did not differ
significantly from any other solutions. The uric acid AUC
did not differ significantly after the G35:F65, G50:G50
and sucrose solutions. In other research(142), only a weak
response of serum uric acid to fructose was found.
Very recently, Wang et al.(143) conducted a systematic
review and meta-analysis of controlled fructose-feeding
trials. The authors noted that hyperenergetic supplemen-
tation of control diets with excessive fructose (þ35 %
excess energy, i.e. 213–219 g/d) significantly increased
serum uric acid compared with the control diets in non-
diabetic participants (mean difference 31·0 (95 % CI 15·4,
46·5) mmol/l). Confounding from excessive energy could
not be ruled out in the hyperenergetic trials, because
no uric acid-increasing effect of tested fructose, isoenerge-
tically exchanged with other carbohydrates, was noted in
either the non-diabetic or diabetic trial.
Zgaga et al.(144) recently observed a positive association
between plasma uric acid and SSB consumption, but no
association with fructose intake, leading the authors to
suggest that fructose is not the causal agent underlying
the SSB–urate association. In another cross-sectional
study(145), it was also concluded that higher dietary
fructose intake was not associated with a higher hyper-
uricaemia risk in healthy adults. This is in line with the
results of a meta-analysis(146) and review(147) that refuted
the relationship between normal dietary consumption of
sugars containing fructose and diabetes.
Final considerations
As discussed, recent findings suggest that high or excessive
fructose intake can induce certain metabolic alterations in
both animal and human models. In this respect, thoughts
regarding the potential harmfulness of excessive fructose
and fructose-containing sugar intakes seem legitimate,
especially in view of the high SSB consumption and the
burdens of obesity and type 2 diabetes.
Based on the currently available data, however, any
statement that ordinary fructose intake is toxic and that
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consumption of fructose-containing drinks are the leading
cause of the global obesity epidemic is not supported by
scientific consensus. We wish to highlight the findings of
Gibson(148), who re-examined the evidence from forty
observational and four intervention studies, as well as six
reviews. She noted that the totality of the evidence was
dominated by American studies and that most studies
suggest that the effect of SSB is small except in susceptible
individuals, involving genetic predispositions, psychologi-
cal factors and environmental stimuli(149), or at excessive
levels of intake (.20 % of total energy). She reported
that progress in reaching a definitive conclusion on the
role of SSB in obesity is hampered by the paucity of
good-quality interventions, which reliably monitor diet
and lifestyle and adequately report effect sizes. Of the
three long-term (6 months) interventions, one reported a
decrease in obesity prevalence but no change in mean
BMI and two found a significant impact only among chil-
dren already overweight at baseline. Of the six reviews,
two concluded that the evidence was strong, one that an
association was probable, while three described it as
inconclusive, equivocal or near zero.
Noteworthy is the study of Pollock et al.(150), who
observed in adolescents that higher fructose consumption
is associated with multiple markers of cardiometabolic
risk, but when visceral adipose tissue was included as a
covariate, it attenuated these associations and showed
that these relationships were mediated by visceral obesity.
Also, Rizkalla(27) concluded that ‘no fully relevant
data have been presented to account for a direct link
between dietary fructose intake and health risk markers’.
A re-evaluation of published epidemiological studies
concerning the consumption of dietary fructose or mainly
HFCS showed that most of these studies have been cross-
sectional or based on passive inaccurate surveillance,
especially in children and adolescents(151), and thus have
not established direct causal links. Research evidence of
the short- or acute-term satiating power or increasing
food intake after fructose consumption as compared with
that resulting from normal patterns of sugar consumption,
such as sucrose, remains unclear. Further, the negative
conclusions regarding fructose have been drawn from
studies in rodents or in human subjects attempting to
elucidate the mechanisms and biological pathways under-
lying fructose consumption by using unrealistically high
amounts of pure fructose. In this respect, we also want
to draw attention to the results of a data analysis by
Livesey(152) who, based on the data of several large
cohorts, concluded as follows:
‘Fructose is proving to have bidirectional effects. At
moderate or high doses, an effect on any one marker
may be absent or even the opposite of that observed at
very high or excessive doses; examples include fasting
plasma triglyceride, insulin sensitivity, and the putative
marker uric acid. Among markers, changes can be ben-
eficial for some (e.g., glycated hemoglobin at moderate
to high fructose intake) but adverse for others (e.g.,
plasma triglycerides at very high or excessive fructose
intake). Evidence on body weight indicates no effect of
moderate to high fructose intakes, but information is
scarce for high or excessive intakes. The overall balance
of such beneficial and adverse effects of fructose is difficult
to assess but has important implications for the strength
and direction of hypotheses about public health, the
relevance of some animal studies, and the interpretation
of both interventional and epidemiological studies. By
focusing on the adverse effects of very high and excessive
doses, we risk not noticing the potential benefits of mode-
rate to higher doses, which might moderate the advent
and progress of type-2 diabetes, cardiovascular disease,
and might even contribute to longevity.’(152)
Conclusion
Through multiple misconceptions about fructose and
fructose-containing sugars, a causal role of their intake
has been proposed in the aetiology of the global obesity
epidemic. However, current evidence on the metabolic
effects of fructose, as consumed by the majority of popu-
lations, is insufficient to demonstrate such a role in meta-
bolic diseases and the global obesity epidemic.
Given the impact of obesity and related metabolic
diseases on health care costs, practical steps to prevent
their development are obviously required. Nevertheless,
implementing taxes on sugary foods and beverages as
suggested is not supported by solid scientific evidence,
and can be expected to be largely insufficient to address
the whole issue of energy overconsumption(153,154). In
this respect, one may rather aim at reducing the consump-
tion of energy-dense foods, which represent a large panel
of sweet and salted foods made largely available in shops,
fast foods and restaurants. The food production and service
industries would be welcome to play a responsible role by
gradually limiting the amount of fat and added sugars in
ready-to-eat or to-drink products to reduce energy density.
In addition, effective policies that facilitate and promote
healthier diets and nutritious food alternatives should be
publicly promoted.
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